Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-04

Clinical Trial Update: A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects [Phase 3]

View source ↗

Summary

Phase 3 study comparing 0.5% ivermectin cream to placebo for head lice infestation; completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ivermectin 0.5% Cream (ivermectin 0.5% cream)

Snippet

Sponsor: Topaz Pharmaceuticals Inc | Conditions: Head Lice | Phase 3 | Status: COMPLETED | Results posted: 2012-04-04